SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
- PMID: 34032997
- PMCID: PMC8145183
- DOI: 10.1007/s15010-021-01629-2
SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
Abstract
Purpose: Seroprevalence surveys from different countries have reported SARS CoV-2 antibodies below 20% even in the most adversely affected areas and herd immunity cannot be predicted till more than half of the population gets the disease. The purpose of this survey was to estimate the magnitude of community-based spread of the infection, associated immunity, and the future prospects and proximity to a 'herd community'.
Methods: The study was undertaken as a cluster randomized, cross-sectional countrywide survey. This largest community-based seroprevalence data of SARS-CoV-2 were collected between 15th and 31st July, 2020 from seven randomly selected cities belonging to the three most populous provinces of Pakistan. The FDA approved kit of ROCHE was used for detection of SARS-CoV-2 antibodies.
Results: Serum samples of 15,390 participants were tested for SARS CoV-2 antibodies with an overall seroprevalence of 42.4%. The seroprevalence ranged from 31.1% to 48.1% in different cities with the highest in Punjab province (44.5%). In univariable analysis, the odds of seropositivity was higher in men compared to women (OR: 1.10, 95% CI: 1.01-1.19, P < 0.05). In multivariable analysis, the risk of being seropositive was lower (OR 0.72, 95% CI: 0.60-0.87, P < 0.01) in younger group (≤ 20 years) than in those aged above 60 years.
Conclusion: The study concluded that despite a reasonable seroprevalence, the country is yet to reach the base minimum of estimations for herd immunity. The durability of immunity though debated at the moment, has shown an evidenced informed shift towards longer side.
Keywords: Antibody; CoV-2; Herd; Immunity; Sars; Seroprevalence.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors of this study declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this study.
Figures
References
-
- Noreen N, Dil S, Niazi S, Naveed I, Khan N, Khan F, et al. COVID 19 pandemic & Pakistan; limitations and gaps. Glob Biosecurity [Internet]. 2020 May 21 [cited 2020 Nov 15]; 1(4). Available from http://jglobalbiosecurity.com/articles/10.31646/gbio.63/
-
- Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020;m1036. - PubMed
-
- WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. Covid19.who.int. 2020 [cited 13 December 2020]. Available from: https://covid19.who.int/?ftag=MSF0951a18
-
- Pakistan Coronavirus: 356,904 Cases and 7,141 Deaths—Worldometer [Internet]. [cited 2020 Nov 15]. Available from: https://www.worldometers.info/coronavirus/country/pakistan/
-
- Unexplained decline in COVID-19 cases’ puzzles health experts [Internet]. Thenews.com.pk.2020 [cited 18 December 2020]. Available from: https://www.thenews.com.pk/print/687387-unexplained-decline-in-covid-19-...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
